Capital Expenditures - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytosorbents Corp
Capital Expenditures Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Capital Expenditures
-$643.1k
CAGR 3-Years
34%
CAGR 5-Years
14%
CAGR 10-Years
-8%
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$723m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$791m
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$612m
CAGR 3-Years
-13%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-68%
CAGR 5-Years
-33%
CAGR 10-Years
-30%

See Also

What is Cytosorbents Corp's Capital Expenditures?
Capital Expenditures
-643.1k USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Capital Expenditures amounts to -643.1k USD.

What is Cytosorbents Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%

Over the last year, the Capital Expenditures growth was 56%. The average annual Capital Expenditures growth rates for Cytosorbents Corp have been 34% over the past three years , 14% over the past five years , and -8% over the past ten years .

Back to Top